Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.0001 par value per share
-
Shares outstanding
-
53.4M
-
Number of holders
-
64
-
Total 13F shares, excl. options
-
5.91M
-
Shares change
-
-707K
-
Total reported value, excl. options
-
$27.1M
-
Value change
-
-$3.37M
-
Put/Call ratio
-
0.76
-
Number of buys
-
27
-
Number of sells
-
-25
-
Price
-
$4.59
Significant Holders of ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) as of Q4 2022
76 filings reported holding ZVRA - ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share as of Q4 2022.
ZEVRA THERAPEUTICS, INC. - Common Stock, $0.0001 par value per share (ZVRA) has 64 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 5.91M shares
of 53.4M outstanding shares and own 11.06% of the company stock.
Largest 10 shareholders include VANGUARD GROUP INC (1.4M shares), BlackRock Inc. (603K shares), Laurion Capital Management LP (571K shares), Janney Montgomery Scott LLC (494K shares), HealthInvest Partners AB (330K shares), GEODE CAPITAL MANAGEMENT, LLC (310K shares), Retirement Planning Co of New England, Inc. (297K shares), Mystic Asset Management, Inc. (176K shares), SUSQUEHANNA INTERNATIONAL GROUP, LLP (170K shares), and Bank of New York Mellon Corp (115K shares).
This table shows the top 64 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.